Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice

Di Zhang(Kingmed Diagnostics), Karen T. Liby(Dartmouth College)
Scientific Reports
January 13, 2021
Cited by 11


Related Papers